Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-867-5 | CAS number: 111-41-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline Study OECD 429 and GLP compliance
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Animals:
- Origin: Harlan Winkelmann GmbH, Gartenstr. 27, 33178 Borchen, Germany
- Sex: Female
- Identification of the animals: The single housed animals were identified by cage cards
- Age at the beginning of the study: ca. 7 weeks
- Body weight range at day 0: 17.1 g – 20.7 g
- Reasons for the selection: The test method was developed in mice.
Housing conditions:
- Air conditions: The animals were housed in fully air-conditioned rooms in which a central air-conditioning system ensured a temperature in the range of 20 - 24 °C and a relative humidity in the range of 30 - 70 %.
- Illumination period: 12 h light (6.00 a.m. - 6.00 p.m.) , 12 h darkness (6.00 p.m. - 6.00 a.m.)
- Type of cage: Makrolon type I
- No. of animals per cage: 1
- Type of diet: Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
- Watering: Tap water ad libitum
- Bedding: Granulat Typ ¾ (staubfrei); SSNIFF
- Acclimatization period: 8 days before the first test substance application - Vehicle:
- other: acetone
- Concentration:
- 1) 3 %
2) 10 %
3) 30 %
4) vehicle acetone - No. of animals per dose:
- 6
- Details on study design:
- The study comprised three treatment groups and a vehicle control group. Each group consisted of 6 mice. A check for dead or moribund animals was made twice each workday and once on Saturdays, Sundays and on public holidays.
No detailed clinical examination of the individual animals was performed but any obvious signs of systemic toxicity and/or local inflammation at the application sites were noted in the raw data.
- Body weights of the individual animals were determined on study day 0 prior to the first application and on day 5 prior to the sacrifice of the animals
- Test substance application: Epicutaneous application is simulating dermal contact with the compound which is possible to occur under practical use conditions.
- Application volume: 25 μL per ear
- Site of application: Dorsal part of both ears
- Frequency of application: 3 consecutive applications (day 0 – day 2) to the same application site
- On study day five (about 66 to 72 hours after the last application of test substance to the ears) the mice were injected intravenously (i.v.) with 20 μCi of 3H-thymidine in 250 μl of sterile saline into a tail vein.
- The animals were sacrificed on study day 5 about 5 hours after 3H-thymidine injection by cervical dislocation.
- Immediately after the death of each animal ear thickness was measured with a suitable gauge (Oditest®-device (measurement steps 0.01 mm), Kroeplin, Germany). Thereafter a circular piece of tissue (diameter 0.8 cm) was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each animal. These measurements serve for detecting a potential inflammatory ear swelling.
- Immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean values and standard deviations of the measured parameters were calculated for the test and control groups from the individual values. The stimulation indices of cell count, 3H-thymidine incorporation, lymph node weight, ear weight and ear thickness measurements were calculated as the ratio of the test group mean values for these parameters divided by those of the vehicle control group. Further statistical analyses ( Cell counts, 3H-thymidine incorporation, lymph node weight, ear weights as well as ear thickness) were performed with the WILCOXON-Test.
- Positive control results:
- The Murine Local Lymph Node Assay is able to show the skin sensitizing effect of Alpha-Hexylcinnamaldehyde, techn. 85 % under the test conditions chosen. The threshold concentration for sensitization induction was between 5 % and 10 % under the test conditions chosen. The EC 1.5 for cell count and the EC 3 for 3H-thymidine incorporation was calculated by linear regression from the results of these concentrations to be 6.9 % and 10.5 % , respectively.
- Parameter:
- SI
- Remarks on result:
- other: control (vehicle) 1.0, 3 % AEEA 2.0, 10 % AEEA 1.72, 30 % AEEA 6.6 EC 3: 15.2 %
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Means: control (vehicle) 444.9, 3 % AEEA 891.1, 10 % AEEA 766.1, 30 % AEEA 2938.3
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Executive summary:
In a dermal sensitisation study with AEEA (BASF AG, Experimental Toxicology and Ecology, 2006) groups of 6 female CBA/Ca mice each were treated with 3 %, 10 % and 30 % w/w preparations of the test substance in acetone or with the vehicle alone using the Local Lymph Node Assay.AEEA shows a skin sensitizing effect under the test conditions chosen. The threshold concentration for sensitization induction was between 10 % and 30 %. The EC 3 for ³H-thymidine incorporation was calculated by linear regression from the results of these concentrations to be 15.2 %.
Reference
- Cell counts, 3H-thymidine incorporation and lymph node weights
When applied as 30 % preparation in acetone, the test substance induced a statistically significant and biologically relevant (increase to 1.5 fold or above of control value = stimulation index (SI) 1.5) increase in cellularity of the auricular lymph nodes. Concomitantly, the increase of 3H-thymidine incorporation into the cells was statistically significant and biologically relevant (increase above the cut off stimulation index of 3). The 10 % and 3 % test substance preparation caused small but statistically significant increases in cellularity of the auricular lymph nodes and 3H-thymidine incorporation into the lymph node cells, which failed to reach the cut off stimulation indices and thus lie below the threshold of immunologic relevance. The lymph node weights were statistically significantly increased in all substance treated groups.
- Ear weights and ear thickness
Statistically significant increases in ear weights and ear thickness were observed in mice treated with the 30 % test substance preparation, which was accompanied by incrustation of the ear skin observed before the third application and on the day of lymph node removal. The 10% test substance preparation caused a statistically significant increase in ear weights, but not in ear thickness. The magnitude of ear skin irritation observed in the test group treated with a 30 % preparation might be considered relevant for evaluating the sensitizing potential of the test substance. As the stimulation indices at this concentration, especially that for cellularity, are well beyond the cut off criteria, an immunologic background of the lymph node response cannot be excluded.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a dermal sensitisation study with AEEA (BASF AG, Experimental Toxicology and Ecology, 2006) groups of 6 female CBA/Ca mice each were treated with 3 %, 10 % and 30 % w/w preparations of the test substance in acetone or with the vehicle alone using the Local Lymph Node Assay.
AEEA shows a skin sensitizing effect under the test conditions chosen. The threshold concentration for sensitization induction was between 10 % and 30 %. The EC 3 for ³H-thymidine incorporation was calculated by linear regression from the results of these concentrations to be 15.2 %.
In a dermal sensitisation study with AEEA in acetone/olive oil 4:1 (AOO) Balb/c mice were tested using the Local Lymph Node Assay (Dearman, 2001). The test concentrations were 2.5, 5.0, 10 and 20 %. The stimulation index for AEEA was > 3, with a maximal value of nearly 15 achieved at the maximum applied concentration of 20 %. The EC 3 concentration was calculated to be 5.3 %. AEEA was a sensitizer in this assay.
In a dermal sensitisation study (Leung, 1997) with AEEA in deionized distilled water young adultpigs (10/sex) were tested using the method of Magnusson and Kligman (Induction 5 % intracutaneous, Induction 50 % epicutaneous, challenge 25 % epicutaneous) according to OECD Guideline 406. In this study 40 % (8/20) of the animals treated with AEEA showed a skin sensitization response (score≥1). AEEA was rated as a moderate dermal sensitiser.
Migrated from Short description of key information:
In three sensitisation studies with AEEA both LLNAs and the guinea pig maximisation test were positive.
Justification for selection of skin sensitisation endpoint:
The key study (BASF AG, 2006) was selected.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available (further information necessary)
- Additional information:
Whitin the LLNA test published by Dearman (2001) decribed above the ability of AEEA to induce cytokines was tested.
According to the authors, the positive response within the LLNA test and the significant expression of the type 1 cytokine Interferon-gamma within the Cytokine Fingerprinting Assay indicate that AEEA possesses contact allergic potential, but lacks significant respiratory sensitizing potential.
Migrated from Short description of key information:
There are no human data available indicative of a respiratory sensitisation. Cytokine profiling performed in a LLNA study using mice indicated that AEEA lacks a significant respiratory sensitisation potential.
Justification for classification or non-classification
Based on the results of the sensitisation studies, AEEA is subject to classification and labelling as follows:
R43 (may cause sensitisation by skin contact) according to Directive 67/548/EEC and Skin sensitizer Cat 1B / H317 (may cause an allergic skin reaction) according to Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.